Thienopyridone derivatives as amp-activated protein kinase (ampk) activators

A compound of the formula (I)

• in which:
• R1 denotes H, A, OA, OH, Hal, NO2, COOA, COOH, CHO, COA, CONH2, CONHA, CONA2, CN, SO2A, SO2NH2, Ar or Het,
• R2, R3 each, independently of one another, denote Ar or Het,
• Ar denotes phenyl, naphthyl, each of which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by A, Hal, OA, OH, CHO, COA, NH2, NHA, NA2, NO2, COOA, COOH, CONH2, CONA, CONA2, SO2A, CN, C(═NH)NH2, C(═NH)NHOH and/or Het,
• Het denotes a mono- or bicyclic unsaturated or aromatic heterocycle having 1 to 4 N, O and/or S atoms, which may be mono-, di- or trisubstituted by Hal, A, Ar′, OA, OH, CHO, COA, COOH, COOA, CN, NO2, NH2, NHA, NA2, CONH2, CONHA and/or CONA2,
• A denotes unbranched or branched alkyl having 1-10 C atoms, in which 1-7H atoms may be replaced by OH, F, Cl and/or Br, or
• denotes cycloalkyl having 3-7 C atoms,
• Hal denotes F, Cl, Br or I,
• and pharmaceutically usable derivatives, salts, solvates and stereoisomers thereof, including mixtures thereof in all ratios,
• excluding compounds of the formula (I) where
• —R1=H ;
• R2=phenyl;
• R3=3-methoxyphenyl
• —R1=H ;
• R2=R3=phenyl
• —R1=H , R2=phenyl, R3=2-thiazoyl.